table of content
1 Study Coverage
1.1 Gastrointestinal Cancer Drugs Product Introduction
1.2 Global Gastrointestinal Cancer Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Gastrointestinal Cancer Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Gastrointestinal Cancer Drugs Sales in Volume for the Year 2017-2028
1.3 United States Gastrointestinal Cancer Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Gastrointestinal Cancer Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Gastrointestinal Cancer Drugs Sales in Volume for the Year 2017-2028
1.4 Gastrointestinal Cancer Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Gastrointestinal Cancer Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Gastrointestinal Cancer Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Gastrointestinal Cancer Drugs Market Dynamics
1.5.1 Gastrointestinal Cancer Drugs Industry Trends
1.5.2 Gastrointestinal Cancer Drugs Market Drivers
1.5.3 Gastrointestinal Cancer Drugs Market Challenges
1.5.4 Gastrointestinal Cancer Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Gastrointestinal Cancer Drugs Market Segment by Type
2.1.1 Oncology
2.1.2 Radiology
2.1.3 Others
2.2 Global Gastrointestinal Cancer Drugs Market Size by Type
2.2.1 Global Gastrointestinal Cancer Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Gastrointestinal Cancer Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Gastrointestinal Cancer Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Gastrointestinal Cancer Drugs Market Size by Type
2.3.1 United States Gastrointestinal Cancer Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Gastrointestinal Cancer Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Gastrointestinal Cancer Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Gastrointestinal Cancer Drugs Market Segment by Application
3.1.1 Hospitals
3.1.2 Specialized Cancer Treatment Centers
3.1.3 Clinics
3.1.4 Ambulatory Surgical Centers
3.2 Global Gastrointestinal Cancer Drugs Market Size by Application
3.2.1 Global Gastrointestinal Cancer Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Gastrointestinal Cancer Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Gastrointestinal Cancer Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Gastrointestinal Cancer Drugs Market Size by Application
3.3.1 United States Gastrointestinal Cancer Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Gastrointestinal Cancer Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Gastrointestinal Cancer Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Gastrointestinal Cancer Drugs Competitor Landscape by Company
4.1 Global Gastrointestinal Cancer Drugs Market Size by Company
4.1.1 Top Global Gastrointestinal Cancer Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Gastrointestinal Cancer Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Gastrointestinal Cancer Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Gastrointestinal Cancer Drugs Price by Manufacturer (2017-2022)
4.2 Global Gastrointestinal Cancer Drugs Concentration Ratio (CR)
4.2.1 Gastrointestinal Cancer Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Gastrointestinal Cancer Drugs in 2021
4.2.3 Global Gastrointestinal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Gastrointestinal Cancer Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Gastrointestinal Cancer Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Gastrointestinal Cancer Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Gastrointestinal Cancer Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Gastrointestinal Cancer Drugs Market Size by Company
4.5.1 Top Gastrointestinal Cancer Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Gastrointestinal Cancer Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Gastrointestinal Cancer Drugs Sales by Players (2020, 2021 & 2022)
5 Global Gastrointestinal Cancer Drugs Market Size by Region
5.1 Global Gastrointestinal Cancer Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Gastrointestinal Cancer Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Gastrointestinal Cancer Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Gastrointestinal Cancer Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Gastrointestinal Cancer Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Gastrointestinal Cancer Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Gastrointestinal Cancer Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Gastrointestinal Cancer Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Gastrointestinal Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Gastrointestinal Cancer Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Gastrointestinal Cancer Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Gastrointestinal Cancer Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Gastrointestinal Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Gastrointestinal Cancer Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Gastrointestinal Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Gastrointestinal Cancer Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Gastrointestinal Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Amgen & Amgen Ireland
7.1.1 Amgen & Amgen Ireland Corporation Information
7.1.2 Amgen & Amgen Ireland Description and Business Overview
7.1.3 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Products Offered
7.1.5 Amgen & Amgen Ireland Recent Development
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporation Information
7.2.2 Bristol-Myers Squibb Company Description and Business Overview
7.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Products Offered
7.2.5 Bristol-Myers Squibb Company Recent Development
7.3 Roche
7.3.1 Roche Corporation Information
7.3.2 Roche Description and Business Overview
7.3.3 Roche Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Roche Gastrointestinal Cancer Drugs Products Offered
7.3.5 Roche Recent Development
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Corporation Information
7.4.2 Eli Lilly and Company Description and Business Overview
7.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Eli Lilly and Company Gastrointestinal Cancer Drugs Products Offered
7.4.5 Eli Lilly and Company Recent Development
7.5 Johnson & Johnson Private
7.5.1 Johnson & Johnson Private Corporation Information
7.5.2 Johnson & Johnson Private Description and Business Overview
7.5.3 Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Johnson & Johnson Private Gastrointestinal Cancer Drugs Products Offered
7.5.5 Johnson & Johnson Private Recent Development
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporation Information
7.6.2 GlaxoSmithKline Description and Business Overview
7.6.3 GlaxoSmithKline Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 GlaxoSmithKline Gastrointestinal Cancer Drugs Products Offered
7.6.5 GlaxoSmithKline Recent Development
7.7 Celgene Corporation
7.7.1 Celgene Corporation Corporation Information
7.7.2 Celgene Corporation Description and Business Overview
7.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Celgene Corporation Gastrointestinal Cancer Drugs Products Offered
7.7.5 Celgene Corporation Recent Development
7.8 Pfizer
7.8.1 Pfizer Corporation Information
7.8.2 Pfizer Description and Business Overview
7.8.3 Pfizer Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Pfizer Gastrointestinal Cancer Drugs Products Offered
7.8.5 Pfizer Recent Development
7.9 Sanofi
7.9.1 Sanofi Corporation Information
7.9.2 Sanofi Description and Business Overview
7.9.3 Sanofi Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Sanofi Gastrointestinal Cancer Drugs Products Offered
7.9.5 Sanofi Recent Development
7.10 Novartis
7.10.1 Novartis Corporation Information
7.10.2 Novartis Description and Business Overview
7.10.3 Novartis Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Novartis Gastrointestinal Cancer Drugs Products Offered
7.10.5 Novartis Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Gastrointestinal Cancer Drugs Industry Chain Analysis
8.2 Gastrointestinal Cancer Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Gastrointestinal Cancer Drugs Distributors
8.3 Gastrointestinal Cancer Drugs Production Mode & Process
8.4 Gastrointestinal Cancer Drugs Sales and Marketing
8.4.1 Gastrointestinal Cancer Drugs Sales Channels
8.4.2 Gastrointestinal Cancer Drugs Distributors
8.5 Gastrointestinal Cancer Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
